Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
An allergic reaction and preventive technology, applied in the direction of allergen antigen components, etc., can solve life-threatening problems
Inactive Publication Date: 2012-11-14
ALK ABELLO SA
View PDF14 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
After each injection, the patient must be under medical supervision for 30 minutes because of the risk of allergic side reactions, which, although extremely rare, can in principle be life-threatening
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0115] Example 1: The effect of SLIT on a mouse model of rhinitis
[0116] Fundamental:
[0117] A rhinitis model was established to test the effect of sublingual immunotherapy (SLIT) in a clinically manifested mouse model.
[0118] method:
[0119] animal
[0120] 6-10 week old female BALB / c mice were housed and maintained on a specific diet that did not contain components that could cross-react with antiserum from Timothy grass (Phlp). Each experimental group included 8-10 animals.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
The present invention relates to a method of preventive treatment of allergy to an allergen in a subject comprising administering an allergy vaccine containing the allergen as active substance to a mucosal surface of the subject, a) wherein the subject to be treated is sensitised so as to exhibit an IgE response specific to the allergen, b) wherein the subject to be treated is free of clinical symptoms of the allergy associated with the allergen, and c) wherein the preventive treatment is aimed at preventing or reducing subsequent clinical symptoms of the allergy associated with the allergen.
Description
field of invention [0001] The present invention relates to a method of prophylactically treating an allergic reaction to an allergen in a subject comprising administering anaphylaxis vaccine to a mucosal surface of the subject. Background of the invention [0002] Allergic reactions are a major health problem in countries adopting a western lifestyle. In addition, the prevalence of allergic diseases is increasing in these countries. Although in general, anaphylaxis is not considered a life-threatening condition, asthma is responsible for a large number of deaths each year. The prevalence of the disorder in about 30% among adolescents results in a significant reduction in quality of life, workday and money, and constitutes a major type of health problem in the Western world. [0003] Anaphylaxis is a complex disease. Allergic events are caused by a variety of factors, including an individual's susceptibility determined by the not-well-understood interplay of several genes....
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/35
Inventor J·布里莫奈斯J·基尔德斯加德
Owner ALK ABELLO SA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap